Mpp Pharma

MPP Pharma is a pharmaceutical company that focuses on the development and manufacturing of high-quality generic medicines, particularly in the areas of infectious diseases such as HIV, Hepatitis C, and Tuberculosis. The company is known for its involvement in licensing agreements with the Medicines Patent Pool (MPP) to produce affordable versions of essential medicines for low- and middle-income countries. By leveraging these partnerships, MPP Pharma aims to increase global access to life-saving treatments through cost-effective manufacturing and distribution. Their portfolio includes a range of antiretrovirals and antivirals designed to meet international quality standards.